PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2023; 14(18):3567. doi:10.7150/jca.92106 This issue Cite

Erratum

Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo: Erratum

Jian-Cai Tang1 Corresponding address, Jia Zhao2, Feng Long3, Jian-ye Chen1, Bo Mu1, Zhen Jiang1, Yonggan Ren1, Jian Yang4

1. Department of Biochemistry;
2. School of Pharmacy;
3. Department of Pharmacy, Nan Chong Central Hospital;
4. Pathogenic Biology and Immunology Experiment Teaching Center, North of Si Chuan Medical University, China.
*Jian-Cai Tang and Jia Zhao contributed equally to this work.

✉ Corresponding author: Jian-Cai Tang, PhD; North of Si Chuan Medical College, Fu jiang Road 234, Shun Qing District, Nan Chong, Sichuan province, China Post code: 637000; E-mail: tangjiancaiedu.cn

Citation:
Tang JC, Zhao J, Long F, Chen Jy, Mu B, Jiang Z, Ren Y, Yang J. Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo: Erratum. J Cancer 2023; 14(18):3567. doi:10.7150/jca.92106. https://www.jcancer.org/v14p3567.htm
Other styles

File import instruction

Corrected-article in J Cancer, Volume 9, 32

 

In the original version of our article, there was two errors in Fig. 4A. Specifically, the representative images of PI3K and AKT of ECA109 cells in Figure 4A are incorrect. The correct image is provided below. This correction will not affect the results and conclusions. The authors apologize for any inconvenience this may have caused.

 Figure 4A 

Shikonin inhibited EGFR/PI3K/AKT signal pathway. Ec109 and EC9706 cells were treated with shikonin(0,2,4μg/ml) for 24h and the total protein were extracted, then the expression of EGFR, PI3K, AKT, p-AKT, mTOR, PKM2 and HIF1ɑ were examined by Western blot. The results showed that shikonin decreased the expression of EGFR, PI3K, AKT, p-AKT, mTOR, PKM2 and HIF1ɑ.

J Cancer Image

Author contact

Corresponding address Corresponding author: Jian-Cai Tang, PhD; North of Si Chuan Medical College, Fu jiang Road 234, Shun Qing District, Nan Chong, Sichuan province, China Post code: 637000; E-mail: tangjiancaiedu.cn

Published 2023-11-28

Citation styles

APA
Tang, J.C., Zhao, J., Long, F., Chen, J.y., Mu, B., Jiang, Z., Ren, Y., Yang, J. (2023). Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo: Erratum. Journal of Cancer, 14(18), 3567. https://doi.org/10.7150/jca.92106.

ACS
Tang, J.C.; Zhao, J.; Long, F.; Chen, J.y.; Mu, B.; Jiang, Z.; Ren, Y.; Yang, J. Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo: Erratum. J. Cancer 2023, 14 (18), 3567. DOI: 10.7150/jca.92106.

NLM
Tang JC, Zhao J, Long F, Chen Jy, Mu B, Jiang Z, Ren Y, Yang J. Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo: Erratum. J Cancer 2023; 14(18):3567. doi:10.7150/jca.92106. https://www.jcancer.org/v14p3567.htm

CSE
Tang JC, Zhao J, Long F, Chen Jy, Mu B, Jiang Z, Ren Y, Yang J. 2023. Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo: Erratum. J Cancer. 14(18):3567.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use